Bluejay Diagnostics, Inc. (BJDX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 14, 2023, details the results of Bluejay Diagnostics, Inc.'s 2023 Annual Meeting of Stockholders. The company is an emerging growth company incorporated in Delaware with its principal executive offices in Acton, MA. As of the record date (May 10, 2023), there were 20,459,057 shares of common stock issued and outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes and Voting Results
Shareholder participation was 67.2% (13,754,302 shares present), constituting a quorum. The following material actions were approved:
- Election of Directors: Stockholders elected Douglas Wurth, Neil Dey, Svetlana Dey, Donald Chase, Fred Zeidman, and Gary Gemignani to serve until the 2024 Annual Meeting. All nominees received significant support, with "Votes For" ranging from approximately 10.65 million to 10.70 million.
- Reverse Stock Split: Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split. The vote was 12,785,699 For, 714,272 Against, and 254,331 Abstain.
- Independent Auditor Ratification: Stockholders ratified the appointment of Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2023. The vote was 13,375,897 For, 88,034 Against, and 290,371 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on operational outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of voting results.
Key Facts for Investor Verification
- Verify the specific ratio of the approved reverse stock split, as the filing confirms approval but does not state the ratio in the text provided.
- Confirm the effective date of the reverse stock split and the subsequent impact on the number of authorized and outstanding shares.
- Review the company's subsequent filings (e.g., 10-K or 10-Q) for financial metrics, as this 8-K contains no financial data.
- Note the high number of broker non-votes (2,790,888) on the director election, indicating shares held by brokers that did not receive voting instructions.